ArticleFrontiers in immunology2026
Human neutrophils recognize group B streptococci
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Comparison of Neutrophil Secretion of Cytokines and NET Formation in Response to Lipopolysaccharide and Group BJournal of inflammation research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Neutrophils, the most abundant leukocyte population, play a central role in host defense against Methods: Neutrophils were isolated from the peripheral blood of healthy donors and stimulated with live and killed GBS or their nucleic acids, in the presence of specific inhibitors of immune recognition receptors. Cytokine responses were assessed by enzyme-linked immunosorbent and quantitative polymerase chain reaction assays, while reactive oxygen species were detected using fluorescence flow cytometry. Results: We initially found that neutrophils produce similar levels of several pro-inflammatory cytokines when stimulated with either live or heat-killed GBS. However, live GBS induce significantly higher levels of interleukin-8 (IL-8) and reactive oxygen species (ROS) compared to killed bacteria by a mechanism that requires activation of formyl peptide receptors 1 or 2 (FPR1 or FPR2). We identified two formylated signal peptides (f-pep8 and f-pep10) which selectively activate FPR1 and FPR2, respectively, promoting neutrophil chemotaxis and ROS generation. We also found that Toll-like receptor 8 (TLR8), but not TLR2, is required for recognition of both live and killed GBS through its ability to recognize bacterial RNA. Discussion: These findings reveal a tripartite sensing mechanism involving TLR8, FPR1 and FPR2, which together amplify neutrophil responses to live GBS. While FPR1 and FPR2 signaling are critical for the augmented production of IL-8 and ROS, they are dispensable for the induction of most other pro-inflammatory cytokines. These data may be useful for better understanding the mechanisms by which neutrophils sense the presence of GBS and for guiding the development of therapeutic strategies targeting innate immune pathways in bacterial infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.